News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Patent News
Avacen Medical Release: New Concept For Chronic Pain Treatment Patent Issued 11/25/2015
Orthocell Key Patents Granted For Celgro And Ortho-ATI 11/25/2015
Synthetic Biologics, Inc. (SYN) Announces Issuance Of First Key U.S. Patent Directly Covering SYN-010, The Company's Novel Candidate For Irritable Bowel Syndrome With Constipation (IBS-C) 11/24/2015
Zero Gravity Solutions Receives Notification Of Patent Approval For Its Commercial Product, BAM-FX From The United States Patent And Trademark Office 11/24/2015
ERS Genomics Licenses Genome-Editing Patents To Regeneron (REGN) 11/24/2015
Therapeutic Solutions International Files Patent On Anticancer Nanotechnology Based Immunotherapy 11/24/2015
Valencell Expands Intellectual Property Portfolio With Critical Patents Enabling Highly Accurate Biometric Fitness And Health Assessments 11/23/2015
The Medicines Patent Pool Signs Licence With Bristol-Myers Squibb (BMY) To Increase Access To Hepatitis C Medicine Daclatasvir 11/23/2015
MiMedx Awarded 12 New U.S. Patents YTD 2015 With Four Awarded For Its Amniotic Membrane Allografts And Eight Awarded For Its CollaFix Technology 11/20/2015
Mylan (MYL) Confirms First-to-File Patent Challenge Relating To DELZICOL 11/20/2015
Arthrex Serves Second Patent Infringement Lawsuit Against Smith & Nephew plc (SNN) 11/20/2015
Cumberland Pharmaceuticals (CPIX) Announces Favorable Acetadote Patent Ruling 11/20/2015
Celator Pharmaceuticals, Inc. Receives Allowance Of Expanded U.S. Claims On CombiPlex Technology 11/19/2015
BioRestorative Granted Key Metabolic Patent 11/19/2015
Ortek Therapeutics Files Patent Applications For New Microbiome Altering Compositions And Methods For Reducing Body Odor Causing Bacteria And Staphylococcus Aureus Proliferation 11/19/2015
PolyPid Ltd. Announces Issuance Of New U.S. Patent For Doxycycline Sustained Release Compositions 11/19/2015
Otoharmonics Receives Patent Approval For Levo Tinnitus System 11/18/2015
CSIRO Maintains Key Patent For shRNA Gene Silencing Technology After European Opposition 11/18/2015
Glytec LLC Receives Approval From The USPTO On Another Patent 11/18/2015
First Singapore Patient Receives Orthocell’s Cartilage Cell Therapy Ortho-ACI 11/18/2015
Cardax Pharmaceuticals Inc. Awarded U.S. Inflammation Patent 11/18/2015
VolitionRX Granted Its Second U.S. Patent 11/17/2015
CEL-SCI (CVM) Is Granted A New European Patent On Its Phase III Investigational Cancer Immunotherapy Multikine 11/17/2015
Patent Approval For BiondVax Pharmaceuticals: BiondVax Receives Approval For Patent In Korea For Its Universal Flu Vaccine 11/17/2015
POXEL Announces Patent Access Agreement With Enyo Pharma 11/17/2015
Zecotek Photonics Inc. Granted Two U.S. Patents For 3D Display System 11/16/2015
Premier Biomedical Receives Notice Of Allowance On Broad Base Patent Involving Innovative Extracorporeal Treatment Therapy – Premier Believes This May Lead To Cancer Cure 11/16/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering VIMOVO (Naproxen/Esomeprazole) Delayed Release Tablets 11/16/2015
U.S. Patent Awarded To Singulex, Inc. For Expanded Use Of Biomarkers Troponin I And T To Detect Cardiac Health Status With Single-Molecule Methods 11/12/2015
Egalet Announces Issuance Of U.S. Patent Covering Guardian Technology And Its Abuse-Deterrent Product Candidates 11/12/2015
Novogen Limited (NVGN) Patent Covering Cantrixil And Trilexium Accepted In Australia 11/12/2015
Merck & Co. (MRK) Statement Regarding CUBICIN (Daptomycin For Injection) Patent Litigation 11/12/2015
Clearside Biomedical Announces Fifth Patent Issued In The U.S. Related To Proprietary Microneedle Drug Delivery Methods And Devices 11/12/2015
Regulus (RGLS) Announces Grant Of Patents Covering Lead microRNA Therapeutics 11/12/2015
Biocept, Inc. (BIOC) Expands Patent Protection In Europe 11/11/2015
Regeneus (RGS.AX) (ASX:RGS) Patent Granted For Allogeneic Stem Cell Technology Platform 11/11/2015
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-221 (Bedoradrine) For The Treatment Of Irritable Bowel Syndrome In Japan 11/11/2015
Hi-Tech Pharmaceuticals Files Lawsuit Against Ironmag Labs And Robert Dimaggio Over Racketeer Influenced And Corrupt Organizations (RICO) And Patent Infringement 11/10/2015
Rock Creek Pharmaceuticals Announces European Patent 11/10/2015
Cellectar Biosciences  (NVLT) Converts Patent Application For Phospholipid-Ether Analogs As Cancer Targeting Drug Vehicles 11/10/2015
Thrasos Strengthens Composition Of Matter Coverage On THR-184 With Japanese Patent Decision 11/10/2015
Syros Pharmaceuticals Announces Issuance Of U.S. Patents Related To Its Gene Control Drug Discovery And Development Platform 11/10/2015
KATOR Granted US Patent For Innovative Suture Anchor Technology 11/9/2015
DS Biopharma Obtains A Granted Patent Covering The Use Of DS102 To Treat Fatty Liver Disorders 11/9/2015
REPLICor Inc. Announces Grant Of US Patents On HBV / HDV Treatment Methods Combining HBsAg Reduction And Immunotherapy 11/9/2015
PTS Diagnostics ' Patent Enforcement Against Jant Pharmacal Gains Momentum 11/6/2015
Singulex, Inc. Receives European Patent Expanding Use Of Biomarkers Troponin I And T To Detect Cardiac Health Status With High-Sensitivity Methods 11/5/2015
Regen BioPharma Files Patent Application On Personalized Checkpoint Inhibitor Cancer Immunotherapy 11/4/2015
BioCad Release: Russian Biotechnological Company Won The Case Against Big Pharma On The Patent Dispute Notable For The Pharmaceutical Industry 11/3/2015
BioRestorative Announces Patent Granted For Its Licensed Curved Needle Device 11/3/2015
Glaukos, Transcend Medical Settle Eye Stent Patent Spat 10/30/2015
BioPharm Executive: From Bad to Worse: Biotech's Next Political Headache? 10/29/2015
In Vitro ADMET Laboratories Announces US Patent On Pooled Cryopreserved Human Hepatocytes For Drug Development Research 10/29/2015
Amarantus BioSciences, Inc. Announces Issuance Of Australian Patent No. 61/057,713 Covering Eltoprazine Treatment Of Parkinson’s Disease And Alzheimer’s Disease 10/29/2015
Fate Therapeutics (FATE) Strengthens Intellectual Property Position With New U.S. Patent Covering Induced Pluripotent Cell Compositions 10/28/2015
Enzymotec Granted A New U.S. Patent For Vayacog In Pre-Dementia 10/28/2015
WaferGen Biosystems Receives Notice Of Patent Grant And Allowance For Methods And Systems Utilizing Multi-Well Chips 10/28/2015
Mesoblast (MSB.AX) Release: Key United States Patent Granted For The Treatment Of Heart Diseases, Stroke And Other Vascular Conditions 10/28/2015
Cancer Genetics (CGIX) Receives Third Patent For Proprietary Genomic FHACT Test, Further Advancing The Detection And Treatment Of Cervical And Other HPV-Associated Cancers 10/28/2015
Regenexx Announces Issue of United States Patent On Proprietary Orthopedic Stem Cell Procedure 10/28/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering VIMOVO (Naproxen/Esomeprazole) Delayed Release Tablets 10/28/2015
Arena (ARNA) Issued Additional Patent Covering BELVIQ (lorcaserin HCl) By United States Patent And Trademark Office 10/27/2015
Twi Biotechnology Receives Notice Of Patent Allowance In Korea For Its Lead Drug Candidate AC-201 For The Indication Of Type II Diabetes 10/27/2015
Endonovo Files Patent Application on Cell Therapy Created Using Its Proprietary Cell-Enhancing Cytotronics Platform 10/27/2015
iBio, Inc. (IBIO) European Protein Expression Patent Emerges From Opposition Period 10/27/2015
Skystar Bio-Pharmaceutical (CGPN) Receives Approval For T-Factor Animal Supplement Patent From PRC's Patent Office 10/27/2015
OrPro Therapeutics Receives US Patent Covering Novel Enzymatic Treatment for Cystic Fibrosis 10/27/2015
Rexahn Pharmaceuticals, Inc. (RNN) Receives U.S. Patent for RX-3117 Anti-Cancer Program 10/27/2015
Orexo AB (ORXOF) Settles Abstral US Patent Litigation With Actavis (ACT) 10/27/2015
Medtronic (MDT) Challenges a Pair of Masimo (MASI) Patents 10/26/2015
Manhattan Scientifics, Inc. Announces Chinese Patent Issued For The Early Cancer Detection Technology Platform 10/26/2015
U.S. Patent And Trademark Office Issues Notices Of Allowance In Two Pending NP-500 Patent Applications Licensed Exclusively By Jaguar Animal Health For Veterinary Use 10/26/2015
Matinas BioPharma Receives Notice Of Allowance Of U.S. Patent For Encochleated siRNA 10/26/2015
First US Patent Covering Allogeneic Chimeric Antigen Receptor T Cells ("CAR-T") Modified To Reduce Immunogenicity Is Awarded To Celyad 10/23/2015
Align Technology, Inc. (ALGN) Files Patent Infringement And False Advertising Lawsuit Against SmileCareClub, Sharper Image, And Brookstone 10/23/2015
Horizon Pharma (HZNP) Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering PENNSAID (diclofenac sodium topical solution) 2% 10/22/2015
Intec Pharma Ltd. Expands Intellectual Property With A New Patent For The Accordion Pill In Europe 10/22/2015
SteadyMed (STDY) Files Inter Partes Review To Invalidate United Therapeutics (UTHR) Patent 10/21/2015
Therabron Therapeutics Receives Notice of Allowance for New EU Patent Supporting its Recombinant CC10 Technology Platform 10/20/2015
Fluoresentric, Inc.USPTO Grants New And Expanded Patent Claims 10/20/2015
XBiotech Strengthens Intellectual Property Portfolio For Its True Human Antibody Technology 10/19/2015
NuGene International, Inc. Files Provisional Patent Applications to Enhance Wound Treatment by Combining Micro-Current Electro-Active Dressings with Human Adipose-Derived Stem Cell Media 10/19/2015
Supernus Pharmaceuticals (SUPN) Announces Settlement With Par On Trokendi XR Patent Litigation 10/15/2015
EyeGate Pharma Receives USPTO Notice Of Allowance For Next Generation Of Proprietary Iontophoretic Delivery System 10/15/2015
LS CancerDiag Receives Patent For Revolutionary Predictive Cancer Diagnostic Method Diagmmr 10/15/2015
Threshold Pharmaceuticals, Inc. (THLD) Receives Two U.S. Patents For Tarloxotinib Bromide 10/14/2015
Angle Release: New Patent Grant 10/14/2015
SpinalCyte, LLC Receives New Australian Patent For Spinal Disc Tissue Engineering 10/14/2015
Glytec LLC Receives Patent On Innovative Diabetes Management Mobile App 10/14/2015
Capstone Therapeutics (CAPS) Announces Allowance Of U.S. Patent For Treatment Of Diabetes With Apo E Mimetic Peptides 10/14/2015
Catalyst Pharmaceuticals (CPRX) Announces Notice Of Allowance Of A U.S. Patent Application For The Method Of Treating Tourette's Disorder With GABA-Aminotransferase Inactivators 10/13/2015
KemPharm Enhances U.S. And Global Intellectual Property Estate 10/13/2015
Enzo Biochem (ENZ) Reaches $10 Million Patent Infringement Settlement With Affymetrix (Santa Clara, California) (AFFX) 10/13/2015
Miacom Diagnostics Announces Issuance Of A Patent For Innovative In Vitro Diagnostic Probes 10/13/2015
Arcadia Biosciences (RKDA) Receives U.S. Patent For Resistant Starch Wheat Technology 10/12/2015
Ignyta (RXDX) Announces Issuance Of Patent Covering Composition Of Matter Of RXDX-107 10/7/2015
Neothetics Announces Issuance By USPTO Of Additional Patent Directed To LIPO-202 Lead Clinical Asset 10/6/2015
InCarda Issued Broad Patents In U.S., Australia And Canada 10/6/2015
Opexa Therapeutics (OPXA) Announces Granting Of New T-cell Patents Covering Tcelna; Patent Estate Increases To 160 Issued Patents 10/6/2015
Cipher Pharma (DND.TO) Announces Settlement In Patent Litigation For Absorica 10/5/2015
RXi Pharmaceuticals (RXII) Bolsters Protection For Its Novel Self-Delivering RNAi Platform With Notice Of Allowance From USPTO 10/5/2015
Inform Genomics Files Provisional Patent Application With United States Patent And Trademark Office (USPTO) -"Systems And Methods For Predicting Treatment-Regimen-Related Outcomes." 10/5/2015
Patent Reveals Apple (AAPL) is Inventing Ring-Style Wearable Device Full of Biosensors 10/2/2015
New Chinese iBioModulator Patent Joins iBio, Inc. (IBIO) Vaccine Portfolio 9/30/2015
United Therapeutics (UTHR) Announces Settlement Of Patent Litigation With Sandoz 9/30/2015
BioMarin (BMRN) Receives Favorable Ruling In The Use Of Exon 51 Antisense Oligonucleotides Patent Interference 9/30/2015
SANUWAVE Receives U.S. Patent For Cleaning And Tenderizing Animal Meat With Shock Waves 9/30/2015
Qu Biologics Granted U.S. Patent For Use Of Staphylococcus Aureus-Based Immunotherapies To Treat Melanoma 9/29/2015
Eagle Pharmaceuticals (EGRX) Receives New Patent For Bendamustine Rapid Infusion Product 9/29/2015
Noven Announces Favorable Decisions In The Inter Partes Reviews Challenging Novartis AG (NVS)’ Exelon Patch Patents 9/29/2015
Therapeutic Solutions International Files Patent On Immune Therapy Medical Device To Prevent Preterm Labor 9/29/2015
RXi Pharmaceuticals (RXII) Granted Patent In China For Lead Clinical Candidate RXI-109 9/28/2015
Hemispherx (HEB) Receives The European Patent Office Grant Of New Composition Of Matter Patent Covering Ampligen Formulations 9/28/2015
GenVec Inc. (GNVC) Expands I.P. Portfolio With Issuance Of U.S. And European Patents For Monkey Adenoviral Vectors 9/28/2015
Sanofi (SNY), Eli Lilly (LLY) Reach Patent Deal on Lantus SoloSTAR 9/28/2015
iX Biopharma Secures Japanese Patent For Waferix Technology 9/28/2015
NovaBone Products Receives Notice Of Allowance For Second Collagen Related U.S. Patent 9/28/2015
SANUWAVE Receives U.S. Patent For Cleaning And Sterilization Of Harvested Tissue For Implantation With Shock Waves 9/24/2015
Pernix (PTX) Announces The Issuance Of Zohydro ER With BeadTek Formulation Patent 9/24/2015
Signal Genetics LLC (SGNL) Granted First European Patent For MyPRS 9/24/2015
PledPharma Release: Key Compound Patent For Pledox And Aladote Set To Gain US Approval 9/24/2015
Oramed (ORMP) Patent Allowed In The US For Oral Administration Of Proteins 9/24/2015
ERYtech Pharma Strengthens Its Intellectual Property Position With The Issuance Of United States Patent For Erythrocytes Containing Arginine Deiminase 9/23/2015
SpinalCyte, LLC Receives New U.S. Patent For Tissue Engineering 9/22/2015
Rosetta Genomics Ltd. (ROSG) Receives U.S. Patent For Treatment Of Prostate Cancer 9/22/2015
Xtant Medical Announces Expanded Patent Coverage of Core Technologies 9/22/2015
India Globalization Capital Release: Patent For Cannabinoid-Based Therapy For Cachexia 9/21/2015
K-PAX Pharmaceuticals Awarded Patent For Repurposing By The United States Patent Office 9/21/2015
Puregraft Issued Foundational Patent By The United States Patent And Trademark Office 9/17/2015
Regen BioPharma Files Utility Patent Application On Immune Based Therapy For Cancer 9/16/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents In Canada And China 9/16/2015
Depomed (DEPO) Files New Patent Infringement Lawsuit Against NUCYNTA ER ANDA Filer 9/15/2015
Vortex Biosciences Granted Critical Patent For Its Liquid Biopsy Technology 9/15/2015
Onxeo Files Application For Key Livatag Patent 9/15/2015
BioBlast Pharma (ORPN) Granted Patent From USPTO For Cabaletta For The Treatment Of Spinocerebellar Ataxia (SCA) 9/14/2015
Suven Life Sciences Ltd Secures Five (5) Product Patents In China, Israel, Mexico, Singapore And Sri Lanka 9/10/2015
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Announces The Publication Of A Report On Macroencapsulated Stem Cell-Derived Insulin-Producing Cells And The Issuance Of Three Patents 9/10/2015
Relmada Therapeutics Announces Issuance Of U.S. Patent Covering SECUREL - An Abuse-Deterrent, Extended-Release, Technology Platform For Opioids 9/9/2015
LabStyle Innovations Receives Granted Patent In The U.S. Expanding Its IP To Address Management Of Chronic Diseases Through Smart Phones 9/9/2015
Glactone Pharma Is Granted A European Patent 9/9/2015
Therapeutic Solutions International Files Patent On Cytokine Modulation To Prevent Pregnancy Loss And Pre-Term Labor 9/9/2015
VolitionRX Granted Its First U.S. Patent 9/9/2015
Allergan (AGN) Announces Agreement With Amneal Related To NAMENDA XR Patent Litigation 9/9/2015
Vanda Pharmaceuticals, Inc. (VNDA) Announces Favorable Markman Ruling In Fanapt Patent Infringement Litigation 9/9/2015
U.S. Patent Granted For Use Of Genticel's Antigen Delivery Vectors In Combination Therapy To Treat Cancer 9/8/2015
Follica Announces Allowance For A U.S. Patent Related To Its Principal Technology Platform To Treat Hair Loss 9/4/2015
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Fifth U.S. Patent Protecting Oxtellar XR 9/3/2015
Mylan (MYL) Confirms The U.S. Patent And Trademark Office Institutes Inter Partes Review Proceeding Against Third Copaxone 40 Mg/Ml Dosing Patent On All Claims 9/2/2015
Pulmatrix Issued New Composition Of Matter Patent Covering iSPERSE Technology 9/2/2015
Nevro Announces Submission Of Preliminary Response To The Patent Trial And Appeals Board 9/2/2015
Reflect Scientific, Inc. Granted Patent For Cryogenic Cooling 9/2/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID (Diclofenac Sodium Topical Solution) 2% 9/2/2015
Swecure's Patent For Prevention Of Allergy In Children Receives US Approval 9/1/2015
Stereotaxis, Inc. (STXS) Awarded U.S. Patent Covering Transmission Of Data For Odyssey Solutions 9/1/2015
ADMA Biologics, Inc. Receives Patent Issuance Pertaining To The Treatment Of Immunodeficiency 9/1/2015
GlycoMimetics, Inc. (GLYC) Announces Issuance Of U.S. Composition Of Matter Patent For Drug Candidate GMI-1271 9/1/2015
Aegis Therapeutics, LLC Awarded Russian Patent For Non-Invasive Delivery Of Triptan Anti-Migraine Drugs 9/1/2015
RedHill Biopharma Ltd. (RDHL) Receives Notice Of Allowance For New Israeli Patent Covering RHB-104 For The Treatment Of Crohn's Disease 8/27/2015
MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 8/27/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID(R) 2% 8/27/2015
Aegis Therapeutics, LLC Awarded Third Patent For Metered Nasal Spray Parathyroid Hormone (PTH) Peptide Drug Formulations 8/27/2015
Acorda (ACOR) Soars as Kyle Bass Loses Challenges to Pharma Patents 8/26/2015
Mylan (MYL) Confirms The U.S. Patent And Trademark Office Institutes Inter Partes Review Proceedings Against Two Copaxone 40 Mg/Ml Dosing Patents 8/26/2015
MTF Receives Favorable Ruling From The Patent Trial And Appeal Board In Patent Dispute With MiMedx 8/26/2015
Corium International, Inc. Announces Issuance Of U.S. Patent For Microcor Transdermal System For A Broad Range Of Therapeutics And Vaccines 8/26/2015
Paradigm Biopharmaceuticals Secures Key U.S. Patent 8/26/2015
Argos Therapeutics, Inc. (ARGS) Awarded Patent For Its Experimental Individualized Immunotherapy For The Treatment Of HIV Infection 8/24/2015
Colibri Heart Valve, LLC Strengthens Patent Portfolio With Receipt Of 12th Transcatheter Heart Valve (THV) Patent 8/24/2015
Molecular Innovations, Inc. Issued U.S. Patent For Human Prorenin ELISA Kit 8/24/2015
MiMedx Patent Infringement Lawsuits Receive Favorable Rulings From Patent Trial And Review Board 8/21/2015
Nuvo Research Inc. (NRI.TO) Announces U.S. Patent For Topical Foamed Formulations That Include DMSO 8/20/2015
Caprotec Bioanalytics Awarded US Patent For CCMS Proteome Profiling Technology 8/20/2015
Amarantus BioSciences, Inc. Announces Issuance Of United States Patent Covering Proprietary Compositions Of Matter And Methods Of Use For Product Candidate MANF 8/20/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering VIMOVO (Naproxen/Esomeprazole) Delayed Release Tablets 8/20/2015
Premier Biomedical Files Patent Application On Cockayne Syndrome Treatment, Which Could Potentially Lead To Major Breakthroughs Against Parkinson's Disease, Alzheimer's Disease And Aging 8/20/2015
Dynasil Announces Xcede Technologies' Patent Application For Novel All-in-One Patch 8/19/2015
Enzymotec Granted U.S. Patent For INFAT To Promote Intestinal Development And Maturation 8/19/2015
Kraig Biocraft Laboratories, Inc. Files For Patent Protection Of Dragon Silk 8/19/2015
Immunomedics, Inc. (IMMU) Extends U.S. Patent Protection For Antibody-Drug Conjugate Program To 2033 8/18/2015
Provectus Biopharmaceuticals Inc. Awarded U.S. Patent Protecting Use Of PV-10 As Part Of Combination Therapy For Cancer 8/18/2015
Mylan (MYL) Confirms First-to-File Patent Challenge Relating to Zytiga 8/18/2015
Cleveland Biolabs Inc. (CBLI) Announces New Patents Strengthening Entolimod Portfolio 8/18/2015
Pluristem Therapeutics (PSTI) Granted U.S. Patent For Production Methods And Use Of Placental Cell Therapy In A Range Of Indications 8/17/2015
Seventh Sense Biosystems Inc. Receives Four Patent Allowances For TAP Blood Collection System In The U.S. And Europe 8/17/2015
Champions Oncology, Inc. (CSBR) Files Patents For Use Of PDX Platform In Immune-Oncology 8/17/2015
Stemedica Cell Technologies, Inc. Awarded U.S. Patent For Transgenic Therapeutic Stem Cells 8/13/2015
Galectin Therapeutics Receives U.S. Patent Notice Of Allowance For Use Of Pectin Compounds To Reduce Fibrosis In Multiple Diseases 8/13/2015
Allergan (AGN) Confirms Generic Noxafil Patent Challenge 8/12/2015
Ceres, Inc. Awarded Patent for iCODE Trait Development System 8/12/2015
Anavex (AVXL) Receives Notice Of Allowance For U.S. Patent Application Related To ANAVEX 2-73 8/12/2015
Dynatronics Corporation (DYNT) Gains Approval Of Its Thermostim Probe Patent 8/12/2015
Nuvo Research Inc. (NRI.TO) Announces Grant Of United States Patent For Topical Onychomycosis Formulation 8/11/2015
AVANIR Pharmaceuticals (AVNR) Prevails In NUEDEXTA Patent Appeal Maintaining Exclusivity Through 2026 8/11/2015
Entest Biomedical, Inc.'s Zander Therapeutics Unit Files Patent Application On Ex Vivo Activated Autologous Immune Cells 8/11/2015
Aegis Therapeutics, LLC Awarded Chinese And Japanese Patents For Non-Invasive Delivery Of Triptan Anti-Migraine Drugs 8/11/2015
iBio, Inc. (IBIO) To Receive U.S. Patent For Influenza Therapeutic 8/11/2015
ControlRad Systems Continues To Strengthen Its Patent Portfolio with Approval Of Fourth Patent 8/10/2015
Manhattan Scientifics, Inc. Announces Issuance Of Additional Patent Covering Detection And Imaging Of Cancer Cells 8/10/2015
BioTime (BTX) Announces the Issuance of 27 New Patents Protecting Stem Cell-Based Product Development 8/10/2015
Neothetics Announces Reaffirmation Of Patents And Termination Of Reexamination Challenge By United States Patent And Trademark Office 8/6/2015